The Committee commends the Taiwan Food and Drug Administration (TFDA), the Ministry of Environment (MOENV), and other relevant authorities for their continued engagement with industry and for the progress made on key regulatory issues in 2025.
Taiwan remains an important and attractive market for the global cosmetics industry, supported by steady consumer demand, ongoing innovation, and continued international investment. At the same time, rapid advancements in digital technologies, including the use of artificial intelligence in product development, compliance, and supply chain management, are reshaping industry operations and increasing both market competition and regulatory complexity.
The Committee looks forward to continued constructive dialogue with regulators and to further collaboration in advancing regulatory transparency and international alignment. Key priorities include the development of a standardized and shareable product information file (PIF) audit FAQ, improvements to the cosmetic product notification system, the introduction of e-labeling, and the promotion of sustainable product design.
In addition, for any new or revised regulatory requirements that involve relabeling or product reformulation, the Committee encourages early government engagement with industry and the provision of sufficient implementation timelines, including clear public communication and appropriate transition periods. Such measures are essential to support effective compliance and minimize disruption to business operations.
Suggestion 1: Initiate meaningful communication between industry and government on cosmetics e-labeling policies.
Cosmetic labeling is a core regulatory tool for ensuring product safety and enabling informed consumer use. Under the Cosmetic Hygiene and Safety Act and related requirements, manufacturers must provide accurate information on product use, ingredients, and precautions. As product portfolios expand and supply chains become more dynamic, maintaining accurate and up-to-date information through paper-based labeling alone is becoming increasingly complex.
Digital labeling offers a practical solution. E-labeling can improve accessibility by allowing consumers to access more detailed and current product information, while supporting sustainability objectives by reducing the use of packaging materials. It also enables more timely updates in response to regulatory changes, safety considerations, or product modifications.
While the TFDA has permitted the use of two-dimensional barcodes, the continued requirement for full paper labeling has confined e-labeling to a supplementary function. As a result, digital tools cannot be used to streamline labeling, reduce the packaging burden, or provide real-time updates, leading to duplicative compliance requirements without corresponding regulatory benefit.
Without a clear regulatory pathway for partial or phased substitution of paper labeling with digital formats, Taiwan risks falling behind international developments and increasing compliance costs for companies operating across multiple markets. This trend may also constrain the growth of e-commerce and digital supply chain management.
The Committee therefore recommends that the TFDA establish a formal e-labeling framework that allows appropriate elements of labeling information — supported by clear standards on accessibility, data integrity, and consumer protection — to be provided digitally in place of paper labels. In developing such a framework, early and structured engagement with industry stakeholders will be essential to ensure that regulatory requirements are both practical and effective.
Suggestion 2: Establish audit guidelines and a risk-based regulatory framework for cosmetic product information files.
With the full implementation of the Cosmetic Product Information File (PIF) system on July 1, 2026, all cosmetics that fall within its scope are required to establish and maintain a PIF. The Committee appreciates the TFDA’s efforts to support implementation of the system though such means as training programs, digital learning resources, and on-site advisory visits conducted by external experts. These initiatives have played an important role in facilitating industry understanding during the transition period.
However, as implementation progresses, several gaps have become apparent. Existing training materials and guidance focus primarily on how to compile PIF documentation, with limited clarity on audit expectations, evaluation criteria, and documentation standards. As a result, companies may adopt differing approaches to structuring their PIFs, while auditors may apply inconsistent interpretations during inspections. This lack of standardization reduces transparency and predictability in the audit process and may lead to increased compliance costs and potential disputes.
International practice, including in the European Union, generally emphasizes the completeness, accessibility, and scientific validity of PIF documentation rather than prescribing rigid formats or templates. Such approaches allow flexibility in documentation structure while maintaining clear expectations regarding safety assessment, good manufacturing practice (GMP) documentation, and supporting evidence.
As Taiwan transitions from implementation to enforcement, clear and standardized guidance regarding the scope, purpose, and schedule of audits is needed to ensure the effectiveness of the PIF system and create regulatory certainty.
The Committee therefore recommends that the TFDA establish a more structured and risk-based audit framework, supported by clear and publicly available guidance, to ensure consistency, transparency, and efficient allocation of regulatory resources.
2.1 Issue clear audit guidelines and reference materials. The TFDA should develop and publish administrative guidance outlining audit procedures, evaluation criteria, and expectations for PIF documentation. Providing illustrative case examples of common deficiencies would enable industry to engage in self-assessment and promote consistent interpretation among auditors.
2.2 Adopt a risk-based audit approach. Audit frequency, depth, and scope should be aligned with product and company risk profiles, taking into account factors such as ingredient risk, product claims, target consumer groups, and compliance history. This process would improve regulatory efficiency and reduce unnecessary burdens on low-risk products.
2.3 Strengthen pre- and post-audit communication mechanisms. Prior to audits, the TFDA could provide briefings or guidance on audit focus areas and expectations. Following audits, in addition to required corrective actions, regulators should provide clear feedback and reasonable timelines for remediation to support effective compliance.
2.4 Support digitalization and data integration in PIF management. The audit framework should be designed to accommodate digital PIF systems, including standardized indexing or tagging approaches that facilitate efficient document access, review, and traceability.
Establishing clear audit guidelines and a risk-based framework would improve regulatory consistency, enhance transparency, and reduce unnecessary compliance costs, while strengthening the effectiveness of the PIF system as a core tool for ensuring cosmetic product safety.
Suggestion 3: Enhance the efficiency and responsiveness of the cosmetic product notification system through user-centered design and proportionate implementation measures.
The Committee appreciates the TFDA’s continued efforts to improve the cosmetic product notification system — the online platform where companies must submit basic information about their cosmetic products (such as ingredients, product type, manufacturer details, etc., before placing them on the market. This process allows regulators to monitor product safety and ensure compliance with relevant regulations.
We also appreciate the TFDA’s openness to industry feedback as it seeks to make those improvements. As the system has become a central platform for product registration and regulatory oversight, its performance directly affects compliance efficiency, the administrative burden, and the overall operating environment for the cosmetics industry.
As system usage increases, practical challenges related to usability, administrative processes, and the implementation of regulatory updates have become more apparent. Addressing these issues will be important to ensure that the system remains efficient, user-friendly, and aligned with the needs of both regulators and industry.
The Committee therefore recommends the following measures:
3.1 Strengthen structured industry engagement and improve system usability. Regular and structured engagement with industry representatives would allow the TFDA to identify operational challenges and prioritize system improvements based on real-world usage. Establishing periodic technical consultations or feedback mechanisms would also support continuous system optimization.
In addition, targeted improvements to system design would enhance efficiency. For example, the current separation of payment processes across various application types (such as new notifications, changes, and extensions) prevents consolidated payment and increases the administrative workload for authorities. Allowing integrated payment functionality would streamline operations and reduce processing time.
3.2 Adopt proportionate implementation measures for regulatory updates. When regulatory changes require companies to revise previously submitted notifications, such revisions are typically driven by compliance obligations rather than voluntary product changes. In such cases, applying standard amendment or re-notification fees may create unnecessary administrative burden without contributing to regulatory objectives.
The Committee therefore recommends that the TFDA waive or adjust such fees where revisions are required solely due to regulatory changes. Adopting a more proportionate approach would facilitate timely compliance, reduce administrative friction, and support effective implementation of new regulatory requirements.
Suggestion 4: Strengthen incentive mechanisms for green design in the cosmetics industry and align cross-ministerial sustainability policies.
The transition toward a circular economy and more sustainable production models is a key policy objective under Taiwan’s Resource Circulation Promotion Act. As a consumer-facing industry with complex product formulations and packaging requirements, the cosmetics sector has a significant role to play in advancing green design, material reduction, and the use of recycled inputs across the product lifecycle.
The Committee recognizes the MOENV’s efforts to promote circular economy principles and establish incentive mechanisms to encourage industry participation. However, current incentive structures are largely designed with other sectors in mind, particularly the food and beverage industry, and do not adequately reflect the technical and regulatory requirements of cosmetic products.
For example, preferential recycling fee conditions for plastic containers, such as no-label designs or simplified packaging structures, are often not applicable to cosmetics. Cosmetic products typically require more complex packaging to ensure product stability, safety, and shelf life, which can extend from three to five years. Requirements related to material opacity, durability, and labeling also differ significantly from those of simpler consumer goods. As a result, many cosmetics companies are unable to benefit from existing incentive schemes, limiting industry participation in green design initiatives.
Without adjustments to these policies, current incentive mechanisms may have limited effectiveness in driving sustainable practices within the cosmetics sector, despite the industry’s willingness to contribute to Taiwan’s environmental objectives.
The Committee therefore recommends that the MOENV strengthen and adapt incentive frameworks to better reflect industry-specific conditions. In particular, the Committee recommends that regulators engage with cosmetics industry stakeholders to develop feasible and targeted incentive measures, including adjustments to recycling fee structures and design criteria that encompass product safety and performance requirements.
In addition, closer coordination between the MOENV and TFDA would support the development of integrated sustainability policies. Aligning environmental and product safety regulations, for example through the promotion of digital labeling and other innovative approaches, would enable more effective implementation of green design strategies while maintaining consumer protection.
A more tailored and coordinated policy approach would improve industry participation in sustainability initiatives, enhance the effectiveness of existing regulatory frameworks, and support Taiwan’s broader transition toward a circular economy.
本委員會肯定衛生福利部食品藥物管理署(TFDA,以下簡稱食藥署)、環境部(MOENV)及相關主管機關於 2025 年持續與產業保持溝通,並於多項重要法規議題上取得實質進展。
台灣持續為全球化粧品產業重要且具吸引力之市場,穩定的消費需求、持續創新以及國際投資動能,均為產業發展提供良好基礎。同時,數位科技快速發展,例如人工智慧(AI)已逐步應用於產品開發、法規遵循及供應鏈管理,正在重塑產業營運模式,亦提升市場競爭及監管複雜度。
本委員會期待持續與主管機關維持開放且具建設性之對話,並進一步深化合作,以促進全球法規調和並提升監管透明度。重點議題包括:建立標準化且可共享之產品資訊檔案(PIF)稽核常見問答(FAQ)、優化化粧品產品登錄系統(notification system)、推動電子化標籤(e-labeling),以及促進永續產品設計(綠色設計)。
此外,針對任何涉及產品改標(re-labeling)或成分調整(reformulation)之新增或修正法規要求,本委員會建議主管機關及早與產業溝通,並提供充分之執行期程、明確之公開溝通及適當緩衝期,以利業者有效遵循法規並降低對營運之影響。
建議一:開啟產官間就化粧品電子化標籤政策進行有意義的溝通
化粧品標籤是確保產品安全性和使消費者能夠充分獲得使用資訊的核心監管工具。根據《化粧品衛生安全管理法》及相關要求,製造商必須提供有關產品用法、成分和使用注意事項等準確資訊。隨著產品組合的擴展和供應鏈的動態變化,僅依賴紙本標籤來維持準確和即時的資訊變得越來越具複雜性。
數位化的標示提供一種務實的解決方案。電子化標籤(e-labeling)不僅提升資訊可近性,讓消費者獲取更加詳盡的現行產品資訊,同時也減少包材的使用以支持永續性目標,亦可就法規異動、安全考量或產品變更進行更即時的更新。
食藥署已允許平行使用二維條碼,但目前仍要求具備完整紙本標籤,使得電子化標籤僅限於輔助功能,因此目前數位工具仍無法實際用於簡化標籤、減少包裝負擔或提供即時更新,導致重複的合規性標示要求,而無法獲得相應的監管益處。
如果沒有清晰的法規來規劃數位形式從而階段性地或部分取代紙本標籤,台灣可能會落後於國際發展上的需求,並增加企業跨市場的合規成本,且可能限制電子商務和數位供應鏈管理的成長動能。
因此,委員會建議食藥署建立一個正式的電子化標籤架構,允許以適當數位形式提供標籤標示項目並部分取代紙本標籤,以清晰的標準來支持可近性、資料完整性和消費者保護。及早與產業就電子化標籤架構的發展進行有組織的討論,以確保法規能夠兼具實用性及有效性。
建議二:建立化粧品產品資訊檔案(Product Information Files, PIF)之稽查指引與風險導向監管體系
隨著化粧品 PIF 制度即將於2026年7月1日全面施行,所有符合定義之化粧品均須依法建立並備妥「產品資訊檔案」(Product Information Files, PIF)。
本委員會肯定食藥署於轉型期間所提供的輔導資源,包含多元的實體與線上培訓課程,以及委外專業團隊進行的 PIF 訪視建議,並數位化後放置於「醫療器材與化粧品數位學習網」(以下簡稱數位學習網)供業者參考。上述輔導資源皆有助於業者在此過渡期更加瞭解PIF制度。
現況觀察,PIF 制度已採分階段實施,數位學習網內稽核及訪視建議相關課程內容多聚焦於「如何建置 PIF 檔案」,而非聚焦稽核準則、審查標準及檔案規範。針對訪視作業,已委外專業團隊提供實地建議,但並不具備與正式稽核一致性之標準化指引,易導致企業在準備文件時依據不同解讀各自建檔,稽核人員在審查時亦可能因缺乏統一標準而產生判準差異。此種「內容理解不一致」的風險,將直接降低稽核之透明度與可預測性,並可能提高合規成本及產生潛在爭議。
參考歐盟在內等國際稽核實務經驗,主要著重於PIF要素之齊全性與維護狀態;稽核時提出輕微觀察事項,如報告順序或優良製造規範(GMP)更新等,無要求特定範本,無一定格式或指定的敘述方式。此實務顯示,稽核重點在於文件可及性、科學依據之完整性,各企業結構可靈活差異。
鑑於稽核機制即將啟動,主管機關應針對稽核範圍、目的與期程,提供明確且標準化的指引,以確保PIF制度有效並建立法規明確性。因此,本委員會建議,食藥署應在既有法律架構下,儘速推動「風險分級稽核」與「稽核指引+主管機關案例說明」,以補足操作層面之缺口。具體建議如下:
2.1 制定內部「PIF稽核檢查清單」與對外公布「稽查計畫」及「稽核指引與案例說明」等參考資料:以「行政指引」或「稽核說明」形式,明確說明;啟動程序與期間之企業義務;檔案結構是否有限制;定期彙編「稽核常見缺失案例集」,作為業界與稽核人員參考。
2.2 導入風險分級稽核模式:依產品風險(如是否含限用成分、特殊族群適用、強效功能或新成分、宣稱強度)與企業歷史合規紀錄,分為不同風險等級及不同稽核深度與抽樣頻率,提升市場監管效率,降低產品之過度稽核。
2.3 強化稽查前後之溝通與輔導:稽核前,舉辦政策說明會;並於稽核結束後,除依規定要求限期改善或下架不合規產品外,提供明確改善建議及合理緩衝期(如分階段修正、文件補充期限等),以協助業者有效落實法規遵循。
2.4 鼓勵PIF管理之電子化與跨機構數據互通:在稽核制度設計中,預留PIF系統之電子化接軌空間(例如:允許企業以電子文件夾系統、內部文件管理系統呈現 PIF,並設定標準化索引與標籤,以利文件之存取、檢閱與追溯),提高效率。
結論,本委員會深切肯定食藥署在 PIF 制度推行過程中,對業界所提供之教育與訪視輔導措施,並認同將 PIF 定位為「產品安全責任核心」之政策方向。然而,為確保制度避免因缺乏統一稽核標準而產生實務落差,建議主管機關在既有法律架構下,儘速建立「PIF稽查計畫與稽核準則」,並推動「風險分級稽核」與「稽核指引+案例說明」之雙軌機制。此舉不僅有助於降低產業整體合規成本,提升稽核之透明度與風險導向性,更能提升PIF確保化粧品安全之實質成效。
建議三:透過以使用者為中心的設計與比例原則之配套措施,提升化粧品產品登錄系統之效率與回應性
本委員會感謝食藥署持續致力於優化「化粧品產品登錄系統」——該線上平台要求業者於產品上市前提交基本資訊(如成分、產品類型、製造商資訊等)。此一機制有助於主管機關監測產品安全並確保符合法規要求。
我們亦肯定食藥署在推動相關優化過程中,持續開放並重視產業意見。隨著該系統已成為產品登錄與監管的重要核心平台,其運作效能直接影響法規遵循效率、行政負擔,以及整體化粧品產業之營運環境。
隨著系統使用量持續提升,與系統易用性、行政流程及法規更新執行相關的實務挑戰亦逐漸浮現。妥善回應這些問題,將有助於確保系統持續維持高效率、使用者友善,並兼顧主管機關與產業雙方之需求。
基此,委員會提出以下建議:
3.1 加強與產業的制度化溝通並提升系統使用便利性
透過定期且制度化的產業溝通,可協助食藥署掌握業界實務操作該系統中所面臨的挑戰,並依據實際使用情形優先推動系統優化。建立定期技術性諮詢會議或回饋機制,亦有助於持續改善系統功能。
此外,針對系統設計進行具體優化,亦可提升整體運作效率。例如,目前不同申請類型(新案登錄、變更及案件展延)之繳費流程相互分離,無法整合付款,增加主管機關與業者之行政負擔。若能導入整合式繳費機制,將簡化流程並縮短處理時間。
3.2 採取符合比例原則的作法以降低法規變動帶來的影響
當法規修訂要求業者針對既有登錄資料進行調整時,該等變更多屬配合法規之必要修正,而非產品本身之自主變更。在此情形下,如仍適用一般變更或重新登錄費用,恐將增加不必要之行政負擔,且未必有助於達成監管目的。
因此,委員會建議,對於僅因法規變更而需進行之資料修正,食藥署可考慮免收或適度調整相關費用。採取更符合比例原則之作法,將有助於促進業者即時遵循法規、降低行政阻力,並提升新制推動之整體成效。
建議四:加強化粧品產業綠色設計的激勵機制,並協調跨部會的永續政策
轉型為循環經濟和永續生產模式是台灣《資源循環推動法》的關鍵政策目標。作為直接面對消費者且產品成分及包裝要求均複雜的化粧品產業,在推動綠色設計、減少包材使用,以及在產品生命週期中使用回收包材扮演重要角色。
委員會認可環境部推廣循環經濟和建立激勵機制以鼓勵產業參與所付出的努力。然而,目前的激勵架構大多是基於其他產業設計,特別是食品和飲料產業,並未充分反映化粧品的技術及監管特性要求。
例如,對於塑膠容器回收的優惠費率,像是無標籤設計或簡化包裝構造,通常難以適用至化粧品。化粧品通常需要複雜的包裝來確保產品安定性、安全性和長達三至五年的有效期間。化粧品對材料的不透明性、耐用性和標籤相關要求,也與簡易形式的一般消費品有所不同。因此,許多化粧品公司無法從現有的激勵規劃中受益,侷限了產業對於綠色設計倡議的參與度。
若未調整相關政策,儘管化粧品產業有意願為台灣的環境目標作出貢獻,現行的激勵機制可能仍在推動該產業的永續實踐方面效果有限。
因此,委員會建議環境部強化並調整激勵框架,以更妥適反映產業特性條件。特別是產官之間交流以制定可行且有目標性的激勵措施,包括對回收費率結構和綠色設計標準的調整,以涵蓋產品安全性和功能的要求。
此外,若環境部與食藥署之間建立更緊密的協調,將有助於發展具整合性的永續政策。例如透過推廣電子化標籤和其他創新方法來取得環境和產品安全法規的一致,以更有效地實施綠色設計策略,同時維護消費者保護。
透過更加量身打造且經過協調的政策,將促進產業對永續倡議的參與,增強現有法規框架的成效,並支持台灣朝向循環經濟進行之整體發展與轉型。
